The Rise of Brain-Computer Interfaces: From Clinical Trials to Real-World Use

Brain-computer interfaces (BCIs) are transitioning from experimental academic curiosities to life-changing medical tools for individuals with paralysis. As clinical trials accelerate globally, new advancements in speech decoding and neural signal processing are offering unprecedented independence to users.

Moving Beyond Point-and-Click Communication

For nearly two decades, BCI research—exemplified by the long-running BrainGate project—was primarily focused on "point-and-click" functionality. This allowed users to control a digital cursor using neural activity, a vital but limited form of interaction. However, the field is currently undergoing a massive pivot toward sophisticated speech decoding.

A prime example is Casey Harrell, an ALS patient and "power user" supported by the University of California, Davis. Using a device implanted in July 2023, Harrell can now "speak" by having software decode his brain signals into phonemes. The technology has become so advanced that it utilizes voice cloning to recreate his original voice, allowing him to communicate with family and maintain his career as a climate activist. The UC Davis team has even implemented high-level software features like privacy modes and profanity filters to refine the user experience.

A Growing Landscape of Commercial and Academic Players

The BCI sector is experiencing an explosion in both participant numbers and corporate investment. While a 2024 study identified only 67 volunteers across 21 research groups since 1998, researchers now estimate that the number of people with implanted brain electrodes has surged to approximately 150.

Several key players are driving this momentum:

• Neuralink: The Elon Musk-founded company reported implanting devices in 21 people over the last two years.
• Synchron: Currently conducting active trials across North America and Australia.
• Neuracle: A Shanghai-based firm that has been trialing devices since November 2024 and recently secured approval for use outside of clinical trials.
• Precision Neuroscience: Developing a BCI that sits on the surface of the brain, offering a different surgical profile than fully implanted models.
• China: Recently became the first country to approve a BCI for general medical use.

Imbangan Teknikal: Tahap Invasif vs. Kualiti Isyarat

Seni bina BCI menentukan kegunaannya. Peranti yang sangat invasif melibatkan elektrod yang ditanam terus ke dalam tisu otak untuk menangkap isyarat berketepatan tinggi daripada neuron tertentu. Walaupun ini menyediakan data terbaik untuk tugas kompleks seperti penyahkodan pertuturan, ia membawa risiko pembedahan yang lebih tinggi.

Sebaliknya, kaedah yang kurang invasif—seperti meletakkan elektrod pada permukaan otak atau menggunakan topi elektrod luaran—menawarkan profil yang lebih selamat tetapi mungkin menghadapi kesukaran dengan kejelasan isyarat. Penyelidikan semasa juga sedang meneroka perbezaan antara sistem berwayar, yang memerlukan port dok pada tengkorak, dan peranti tanpa wayar yang ditanam sepenuhnya yang menjanjikan mobiliti dan kemudahan penggunaan yang lebih besar.

Cabaran di Hadapan

Walaupun terdapat kemajuan yang pesat, halangan besar masih wujud. Ketahanan jangka panjang implan ini masih menjadi persoalan; dalam beberapa kes ALS, peranti yang pada mulanya menyediakan komunikasi telah berhenti berfungsi secara tidak dijangka. Memahami mengapa kegagalan ini berlaku dan menentukan cara untuk memanjangkan jangka hayat peranti merupakan sempadan besar seterusnya bagi penyelidik dan jurutera BCI.

Intipati Utama

• Peralihan Fungsi: Teknologi BCI sedang beralih daripada kawalan kursor yang mudah kepada penyahkodan pertuturan masa nyata yang kompleks dan pengklonan suara.
• Penskalaan Pantas: Bilangan peserta ujian BCI telah meningkat lebih daripada dua kali ganda sejak awal 2024, didorong oleh syarikat seperti Neuralink, Synchron, dan Neuracle.
• Percabangan Teknikal: Industri ini sedang mengimbangi antara implan invasif isyarat tinggi dengan elektrod tahap permukaan atau boleh pakai yang lebih selamat dan kurang invasif.